Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
December 04 2017 - 4:29PM
Edgar (US Regulatory)
|
|
OMB APPROVAL
|
|
|
OMB Number:
3235-0167
|
|
UNITED STATES
|
Expires:
March 31, 2018
|
|
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
Estimated average burden hours per response 1.50
|
FORM 15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission
File Number: 000-55016
AMARANTUS BIOSCIENCE
HOLDINGS, INC.
(Exact name of registrant
as specified in its charter)
315 Montgomery Street,
Suite 900San Francisco, CA 94104 (408) 737-2734
(Address, including zip
code, and telephone number, including area code, of registrant’s principal executive offices)
Common
(Title of each class of securities covered by this
Form)
(Titles of all other classes of securities
for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X
in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
Rule 12g-4(a)(1)
|
☒
|
|
Rule 12g-4(a)(2)
|
☐
|
|
Rule 12h-3(b)(1)(i)
|
☐
|
|
Rule 12h-3(b)(1)(ii)
|
☐
|
|
Rule 15d-6
|
☐
|
|
Rule 15d-22(b)
|
☐
|
Approximate number of holders of record as of the
certification or notice date:
88
Pursuant to the requirements
of the Securities Exchange Act of 1934
(Name of registrant as specified in charter)
has caused this certification/notice
to be signed on its behalf by the undersigned duly authorized person.
Date:
|
12/4/2017
|
|
By:
|
/s/ Gerald E. Commissiong
|
|
|
|
|
|
Gerald Commissiong, Chief Executive Officer
|
|
Instruction: This form
is required by Rules 12g-4, 12h-3 and 15d-6 and 15d-22 of the General Rules and Regulations under the Securities Exchange Act of
1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed
by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the
form shall be typed or printed under the signature.
Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Sep 2023 to Sep 2024